|
|
Home > Healthcare > Biotechnology > Cell/Tissue Engineering
European Markets for Advanced Wound Management
|
| Published Date:
October 2006
Published By:
Frost & Sullivan
Page Count:
86
Order Code:
R1-5181
|
|
|
|
Research Overview
This Frost & Sullivan research service titled European Markets for Advanced Wound Management provides an analysis of wound dressings and therapies that fall into the category of advanced wound management products. This study offers a description of key market drivers, restraints and trends influencing the adoption of wound management products. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: moist wound dressings, antimicrobial wound dressings, advanced therapies, negative pressure therapy.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Moist wound dressings
- Antimicrobial wound dressings
- Advanced therapies
- Negative pressure therapy
Technologies
The following technologies are covered in this research:
- Hydrogels
- Alginates
- Hydrofibers
- Hydrocolloids
- Foams and Films
- Silver and Others
- Bio-interactive and Tissue Engineering
Market Overview
Innovation and Improved Clinical Outcomes Drive Demand for Advanced Products for Wound Healing
The advanced wound management markets in Europe are expanding and the shift from traditional to advanced wound dressings is expected to continue in the future. This shift can be attributed to the development of innovative products, increased acceptance by healthcare decision-makers, improved clinical efficacy and reduced costs of total care. These products produce benefits such as increased comfort, less changing time for dressings, faster healing and reduced complications of further infection.
"Advanced wound management products have demonstrated clinical efficacy," notes the analyst of this research service. "Good clinical outcomes in terms of wound healing and reduction in infection have increased their acceptance and improved the willingness of medical professionals to use such products. In addition, patients are increasingly becoming well-informed and demonstrating preference for certain treatments in situations where they can influence the choice of treatment."
Greater Penetration of Existing Products and New Product Development Crucial for Market Growth
Chronic wounds are often a source of morbidity and can lead to complications such as infections, contractures, depression or limb amputation, which can result in considerable disability. In this scenario, higher mortality and the need for assisted living have a significant impact on public health and healthcare expenditure. Overall, it is estimated that the management of all types of wounds may account for two to four per cent of total healthcare expenditure in each country of the European Union. This is in addition to other costs to society and the impact of such conditions on the quality of the patient’s life.
The development of new treatment therapies, initiatives and products aimed at avoiding or reducing wounds is a potential threat faced by the existing advanced wound management products in the market. Moreover, alternative/innovative therapies that have proven patient improvement and long-term cost-effectiveness have gained in popularity. As a result, therapies such as negative pressure are hampering growth in other market segments such as moist wound dressings and anti-microbial wound dressings. Hence, strategies to counter these threats include greater penetration of current products, as well as new product development. "Success of wound management therapies have resulted from therapies that combine assured effect with attributes," explains the analyst. "Several advances are resulting from a greater understanding of the body's processes and the ability of science to speed up natural healing processes." Accordingly, market revenues are projected to grow from $962.0 million in 2005 to reach $3043.4 million in 2012.
|
Similar Products
• Regenerative Medicines: Bone and Joint Applications
Published Oct 2009 by BCC Research
• Stem Cell Markets
Published Jun 2009 by Trimark Publications
• Growth Factors (Blood And Tissue)
Published Oct 2008 by Global Industry Analysts
• Advances in Replacement Organs and Tissue Engineering (Technical Insights)
Published Sep 2008 by Frost & Sullivan
• Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
Published Mar 2008 by Kalorama Information
• Tissue Engineering and Cell Transplantation: Technologies, Opportunities, and Evolving Markets in the U.S.
Published Jul 2007 by Medtech Insight
• Stem Cell - Analysis and Market Forecasts, 2006-2016
Published Mar 2007 by RRY Publications
• Tissue Engineering & Stem Cell Technology Report 2007
Published Feb 2007 by Visiongain
• Hitting the Bull's-Eye with Your Eyes Closed: The Stem Cell Magic Bullet
Published Dec 2006 by IDC
|
|
|
|
0 items
